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Purpose:This study compares early results of video-assisted thoracoscopic sympathectomy (VTS) at the thoracic T2 versus
T3 ganglion denervation levels for the treatment of palmar hyperhydrosis (PH).
Methods: Sixty patients with PH were prospectively randomized for VTS at the thoracic T2 or T3 ganglion denervation
levels. The patients underwent postoperative evaluation on three occasions: before surgery, and 1 and 6 months after the
operation. Endpoints included the absence of PH, the presence, location, and severity of compensatory hyperhydrosis
(CH), and a quality-of-life assessment.
Results: Fifty-nine of 60 patients reported complete resolution of PH after surgery. One failure occurred in the T3 group.
CH was observed in 26 patients (86.66%) in the T2 group and in 27 patients (90%) in the T3 group at 1 month. At 6
months, 30 of 30 patients in the T2 group and 29 of 30 in the T3 group experienced CH, although in the T3 group, CH
was less severe at both 1 and 6 months (P< .05). Quality of life was very poor in both groups before surgery. One month
after operation, quality of life was improved similarly in both groups. This improvement was maintained at 6 months in
both groups.
Conclusion: PH is well treated by VTS at either the T2 or T3 levels. Denervation at the T3 level appears associated with
less severe CH in the early postoperative period. Quality of life improved significantly in both groups. (J Vasc Surg 2005;
42:281-5.)Video-assisted thoracoscopic sympathectomy (VTS) is
the treatment of choice for palmar hyperhidrosis (PH).
This technique avoids manipulation of the stellate gan-
glion, thus minimizing the occurrence of Horner’s syn-
drome.1-3 However, VTS is associated with the develop-
ment of compensatory hyperhidrosis (CH), with an
incidence ranging from 30% to 90%.4-8 The level of the
ganglia resection that successfully treats PH while minimiz-
ing the incidence and severity of CH is unknown.9-11
This study compares the early results of VTS at two
levels of denervation, thoracic ganglion T2 versus T3, in a
prospective randomized manner. Patients were followed
for PH, CH, and quality of life.
METHODS
From May 2003 to January 2004, 60 patients with PH
underwent VTS. All consented to enter a prospective,
randomized study designed according to the guidelines of
the Ethics Committee for Analysis of Research Projects on
Human Experimentation at the study institution. Patients
were included in this study if they had not had thoracic
operations and had no disease or associated condition, such
as cardiac diseases, pulmonary infections, neoplasia, or in-
flammatory diseases affecting the lungs or pleurae, which
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risk. Patients with a body mass index 25 were excluded.
After randomization, 30 patients underwent VTS at the
T2 ganglion level and 30 at the T3 level. All the patients
were blinded to the level of sympathectomy. All the proce-
dures were performed by the same surgical team, and
standard surgical techniques were used throughout the
study period.
All patients underwent surgery under general anesthe-
sia and in a semi-seated position inclined at 60°. Two 5-mm
mini-incisions were made. The first was at the fourth inter-
costal space on the anterior axillary line, into which a video
camera was introduced. The second was at the fourth
intercostal space on the medial axillary line, into which the
electric or harmonic cautery was introduced.
The level of ganglion resection was selected at random.
After identification of the sympathetic chain, the patients
randomized for the T2 ganglion level underwent resection
of the chain (sympathicotomy) on the body of the second
and third ribs, followed by thermoablation of the segment
isolated between them. The patients randomized for the T3
ganglion level underwent resection of the chain (sympathi-
cotomy) on the body of the third and fourth ribs, followed
by thermoablation of the segment isolated between them.
During thermoablation, the adjacent ganglia were pro-
tected from any transmitted heat. The same procedure was
performed on the contralateral chain.
The patients were had a clinical and quality-of-life
assessment once before surgery and then at 1 month and 6
months after the operation. The primary investigator did all
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were:
1. Presence or absence of palmar anhydrosis, as reported
by the patient and confirmed by physical examination.
2. Presence or absence of CH, with evaluation of its loca-
tion and severity, as reported by the patient and con-
firmed by physical examination. The severity of the CH
mentioned spontaneously by the patients was graded as
severe or nonsevere. The CH was considered to be
severe if it was visible, embarrassing, and necessitated
more than one change of clothes during the day.
3. The patient’s degree of satisfaction was measured by the
quality-of-life protocol described by Amir et al.12 Pa-
tients completed the quality-of-life assessments without
physician involvement. The patient’s preoperative qual-
ity of life was classified in one of five different levels of
satisfaction by summing the points obtained from this
questionnaire. When the total 84, we considered that
the preoperative quality of life was very poor; 69 to 84,
poor; 52 to 68, good; 36 to 51, very good; and 20 to 35,
excellent. The quality of life assessment was repeated at
1 and 6 months after operation, and the patients were
similarly classified in one of five different levels of satis-
faction according to their score: much worse when the
total 84; little worse, 69 to 84; unchanged, 52 to 68;
a little better, 36 to 51; and much better, 20 to 35.12,13
Statistical analysis. For categoric variables, the 2 or
Fisher’s exact frequencies test were used, depending on the
sample, for verifying associations between the type of sur-
gery and the possible results and complications. These
statistical tests for comparing the types of surgery with the
variables of interest (palmar anhydrosis, incidence and se-
verity of CH, and quality of life) were performed in relation
to each of the assessment periods. The association between
patients’ ages and degrees of satisfaction measured by the
quality-of-life protocol and the level of ganglion resection
(T2and T3) were performed using the Mann-Whitney U
test. The significance level considered for all tests was 5%.
RESULTS
The mean ages and the sex distribution of the two
groups selected by the randomization process were similar
(Table I). During the immediate postoperative period, all
the patients denied episodes of PH. One patient had tran-
sitory (1 month) right-side Horner’s syndrome, likely at-
tributable to heat transmission during the lysis of pulmo-
Table I. Clinical characteristics of the patients with
palmar hyperhidrosis
T2 T3 P*
Mean age  SD 23.4  5.3 23.2  6.5 .5833
Men/women 24:6 17:13 .052
*Values were not significantnary adhesions. Pleural drainage was necessary in onepatient in each group because of significant pleural adher-
ence.
No PH was reported at the 1- and 6-month follow-up
visits by any of the 30 patients who underwent sympathec-
tomy at the T2 level. One patient in the T3 group had
continued PH. This patient underwent repeat thermoabla-
tion at the same level (T3), with no reduction in the PH.
This patient is receiving clinical treatment with anticholin-
ergic drugs and experiencing a slight reduction in the PH.
CH was observed in 26 patients (86.66%) in the T2
group and 27 patients (90%) in the T3 group at the
1-month follow-up. At the 6-month follow-up, all patients
in the T2 group had some degree of CH, and all but one
patient in the T3 group (96.6%) had CH as well. The
patients in the T3 group had a lower degree of severity of
CH at both the 1-month and 6-month follow-ups (P 
.05). The degree of CH in the two groups is presented in
Table II.
No differences in the preferential location for CH
were observed between the two groups: the abdomen,
back region, or both, were affected. There was also no
difference in the situations that triggered CH for both
groups. CH occurred preferentially in situations of ex-
cessive heat, physical exercise, or both. A small number
of patients mentioned that the symptom appeared in
relation to stress.
The patients’ degrees of satisfaction measured by the
quality-of-life protocol are presented in Table III.
Before surgery, the quality of life was very poor in both
groups (median,84). One month after the operation, the
quality of life was much improved in both groups, without
significant difference between them (P  .8423). This
improvement was sustained at the 6-month follow-up (P






T2:T3 P T2:T3 P
Nonsevere 16:27 .001 20:26 .033
Severe 10:0 10:3
Table III. Point totals on quality-of -life questionnaire
Variable T2 T3 P*
Initial (before operation)
Median (range) 92 (67-100) 87.5 (75-100) .3052
1-month follow-up
Median (range) 23 (20-47) 23 (20-42) .8423
6-month follow-up
Median (range) 24 (20-56) 24 (19-52) .3905
*Obtained by Mann-Whitney U test.3905).
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PH can be defined as a somatic disorder characterized
by excessive perspiration in the palmar region. It is caused
by hyperfunctioning of the sudoriparous glands, which are
frequently triggered by emotion. Sympathectomy is indi-
cated in cases of essential (emotional) hyperhidrosis that
does not present any relationship with the need for ther-
moregulation.
Clinically, PH seems to be more severe during the
period of hormonal and sexual maturation (ie, adoles-
cence), although it may exist from the time of infancy.14,15
PH is usually bilateral and symmetrical. PH has greater
importance than hyperhidrosis in other localities, such as
axillary and craniofacial hyperhidrosis, because of the re-
sulting problems of social, professional, and affective na-
ture. PH may cause a condition of social phobia in some
individuals.
When we perform the T2 technique, we are probably
resecting the second sympathetic ganglion in most cases, as
defended by Ramsaroop et al,16 who studied 22 adult
cadavers and demonstrated that the second thoracic gan-
glion was consistently located in the second intercostal
space. Also, Chung el al17 observed that in 27 adult cadav-
ers, the second thoracic sympathetic ganglion was most
commonly located (50%) in the second intercostal space.
A positive response of PH to sympathectomy has been
long known. In our sample, therapeutic failure only oc-
curred in one case in the T3 group. PH was not reduced in
this patient, despite a second surgical intervention. This
suggests a small number of patients may have a neurologic
bypass via T2 ganglion fibers or postganglionic fibers in T2
that could maintain the PH in patients who undergo VTS
at the T3 ganglion level.
With the advent of VTS, Horner’s syndrome has
become a rare complication. Its occurrence is limited to
cases of indirect injury to the stellate ganglion caused by
heat diffusion or excessive traction of the sympathetic
chain.15 We believe that resecting ganglia that are more
distant from T1 should reduce the incidence of this
complication further. In our study, only one case of
Horner’s syndrome occurred, caused by transmission of
heat in a patient in the T3 group who presented with a lot
of pleural adherences.1,13
The postoperative appearance of perspiration in regions of
the body where it had not been previously observed is called
CH.18,19 Its physiopathology is unknown, but it is suspected
that this phenomenon is caused by a temperature-regulating
compensatory mechanism in the body.11 It occurs most fre-
quently in the back region and abdomen.4
CH is the most common complication reported with
VTS10,19,20-22and was so in our study. When severe, CH
can significantly affect quality of life.13 In the present study,
this complication occurred in 100% of the patients in the
T2 group and 96.6% of the T3 group. The severe form was
present in 33.3% of the patients in the T2 group and in 10%
of the T3 group.We believe that this high incidence is because Brazil is a
tropical country, and the weather is most frequently hot,
which naturally generates more sweating. This can be con-
sidered to be a normal physical response to high ambient
temperatures. Nonetheless, postoperative CH can occur
irrespective of how hot the environment is.
Another reason for the high incidence of CH is the
conservative definition of CH adopted for this trial. At
present, there is no consensus for the classification of CH.
Because of this, we have created a comprehensive method
in which we considered CH to be present if perspiration
occurred in locations of the body where it had not existed
before the surgical procedure, even if such sweating was
only observed under specific conditions such as intense heat
or physical exercise. Other methods for quantifying the
severity of CH take into consideration situations of daily life
that could indirectly indicate the quantity of sweat.20
We graded the 60 in our study into two groups of
severity. Patients were considered to have severe CH if they
inquired about additional therapy or if sweat soaked their
clothes to the point of being visible and embarrassing and,
because of such severity, needed to change their clothes
more than once during the day. Those who presented with
CH in situations of heat, exercise, or stress that could be
visible or embarrassing, but without the need for more than
one change of clothes or treatment, were graded as having
nonsevere CH.
It has been suggested that CH has a correlation with
the extent of the resection and also the level of the resec-
tion.23,24 In the present series, one ganglion (T2 or T3)was
resected in each of the two groups. Because the extent of
the resection was the same, our results suggest the level of
the neuroablation may be the most important factor. Oth-
ers have reported similar results.
In 2001, Lin and Telaranta25 reported that CH was less
prevalent in patients who underwent T3 and T4 ganglion
resection than in patients with T2 ganglion ablation. They
theorized that the higher the interruption or resection in
the sympathetic chain was performed, the more afferent
fibers responsible for inhibiting sudoresis would be dam-
aged, thereby causing a considerable increase in the quan-
tity and severity of CH.25
Leseche et al10 used different levels of sympathectomy
in patients with PH and observed a therapeutic success rate
of 97% and CH in 71% of the cases. Their study compared
several levels of sympathectomy but did not evaluate the
levels T2 and T3 separately.
Riet et al11 retrospectively analyzed sympathectomy of
the T3 ganglion in just 14 patients, reporting therapeutic
success in all cases and an absence of CH after the opera-
tion. Hsu et al,6 in a retrospective study, observed CH in
70% of the patients who underwent sympathectomy at the
T3 and T4 ganglion levels, in 29% at the T4 ganglion level,
and in 29% at T4-T5 ganglion.
Yoon et al26 used sympathicotomy at the level of the
third rib in 24 patients with PH. This achieved resolution of
the PH in all patients, with low incidence of CH (1 patient).
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sympathicotomy at the levels of the second and third ribs in
one group compared with simple sympathicotomy at the
level of the third rib (T3). They obtained therapeutic
success in all patients and reduced incidence of CH in the
T3 group (45.8% vs. 16.73%).27
The data obtained in our study, contrary to some of the
above-mentioned studies, show similar incidence of CH in
the T2 and T3 groups (100% and 96.77%). With regard to
the severity of the CH, our results are similar to those in
which CH is more severe after the higher resections than
after the lower resections (33% vs 10%; P  .033).
In our environment, excessive sweating may be consid-
ered to be unaesthetic, may cause distress in social situa-
tions, and may become dangerous and incapacitating. Such
traits usually begin during infancy and may worsen during
adulthood. The quality of life of patients with PH can be
severely affected.
Several studies have reported an improvement in qual-
ity of life after sympathectomy, despite postoperative pain
and the presence of CH in most patients.28 These elements
were outweighed by the improvement in patients’ palmar
symptoms, social roles, mental and physical functioning,
and overall quality of life.29
In our study, the scores from the quality of life ques-
tionnaire before the operation confirmed that the quality of
life of patients with PH was very poor, with no statistical
difference between the groups (median, 92 for T2 and 87.5
for T3). Quality of life was notably improved after the
operation, as shown by the reduction in the questionnaire
scores from 92 to 24 in the T2 group and from 87.5 to 24
for T3. Despite the difference in the severity of CH be-
tween the groups, there was no difference in patients’
satisfaction after the procedure. This was shown in the
notable improvement in quality of life for both groups,
both at the 1-month (median, 23) and 6-month (median,
24) follow-ups. Perhaps if we had not had a therapeutic
failure in the T3 group, the quality of life might have been
greater than for the T2 group.
CONCLUSION
VTS at the T2 or T3 ganglion effectively treats for PH.
CH is a likely complication of the procedure. Despite the
occurrence of CH, patients’ quality of life is significantly
improved after VTS at T2 or T3. VTS at the T3 level
appears to be associated with a less severe form of CH, even
though the improvement in quality of life was similar for
the two groups. For this reason, it is presently our preferred
treatment for PH.
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